NEW YORK – Progenity is seeking a declaratory judgment from a court that the in-house use of its Innatal noninvasive prenatal test and related activities do not infringe six patents held by Natera.
NEW YORK – Progenity is seeking a declaratory judgment from a court that the in-house use of its Innatal noninvasive prenatal test and related activities do not infringe six patents held by Natera.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.